pharmaphorum

JUNE 17, 2025

Skip to main content Tuesday 17 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 89

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 89

pharmaphorum

JULY 17, 2025

Skip to main content Thursday 17 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Immunity 52

Immunity Immunization Diabetes Pharmaceutical Companies 52

pharmaphorum

JUNE 24, 2025

Skip to main content Tuesday 24 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

pharmaphorum

JUNE 27, 2025

Skip to main content Friday 27 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Drug Development 52

Drug Development Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

STAT

AUGUST 22, 2024

In 2015, the FDA began reporting on the representation of individuals in clinical trials, with the hope that raising awareness would drive meaningful change. Lack of diversity occurs at all levels of the pharmaceutical ecosystem, from the makeup of C-suite and research staffs to participation in clinical trials.

Drug Development 313

Drug Development 313

European Pharmaceutical Review

JUNE 27, 2022

DRUG DEVELOPMENT based on targeted protein degradation (TPD) has progressed rapidly since the publication in 2015 of three landmark papers 1-3 that highlighted important early-stage breakthroughs with drug-like molecules in this area of research.

Drug Development 105

Drug Development Pharmaceutical Companies Pharmaceutical Companies 105

European Pharmaceutical Review

DECEMBER 16, 2022

In 2015, Alzheimer’s Therapeutics International found there was an estimated 46.8 According to Alzheimer’s Therapeutics International in 2015, 58 percent of people with dementia live in developing countries, but by 2050 this will rise to 68 percent. percent, and driven largely by collaboration of existing players, reach $6.8

Compounding 98

Compounding Immunization Immunity Drug Development 98

European Pharmaceutical Review

JANUARY 9, 2024

Accelerated drug discovery: Simulations and predictive models powered by AI will speed up the drug development process, effectively slashing time to market for drugs. 2015; 13:8-17. 2015; 12(10):931-934. IEEE J Biomed Health Inform. 2018; 22(5):1589-1604. Kourou K, Exarchos TP, Exarchos KP, et al.

Pharmaceutical Manufacturing 122

Pharmaceutical Manufacturing Drug Development 122

Pharmaceutical Technology

JULY 21, 2022

AI also speeds up the drug development process, which could translate into cheaper drugs for patients. Aprecia Pharmaceuticals’ Spritam, an anti-epileptic drug, is the first and only 3D-printed pharmaceutical, having received US Food and Drug Administration (FDA) approval in 2015. 3D printing.

Drug Development 98

Drug Development Hospitals 98

pharmaphorum

OCTOBER 31, 2022

The small-molecule PIKfyve inhibitor – called VRG50635 – has been administered to the first subject in the phase 1 trial involving healthy volunteers, according to the San Francisco-based biotech, which was founded in 2015 by Alice Zhang and Jason Chen.

Compounding 136

Compounding Drug Development 136

pharmaphorum

AUGUST 26, 2021

There are many benefits of including patients at every stage of the drug development process, as well as ways to involve them in the early stages of drug development. It helps to focus the drug development process on its main element – the patient, and it also makes good business sense, too.

Drug Development 105

Drug Development Communication 105

pharmaphorum

MARCH 24, 2022

GlaxoSmithKline has thrown its financial and drug development weight behind LifeMine Therapeutics, a US startup that aims to find new therapeutics from fungi – widely regarded as an underexplored resource of biologically-active compounds. Greg Verdine – LifeMine.

Compounding 105

Compounding Immunization Immunity Drug Development 105

European Pharmaceutical Review

JULY 7, 2022

Dr Eric Hughes joins Teva with experience in all phases of drug development at global pharmaceutical companies, most recently Boston-based Vertex Pharmaceuticals, which he joined last year. He will be based out of Teva’s US headquarters in Parsippany, New Jersey. . Dr Hughes earned his MD and PhD at Yale School of Medicine.

Research Laboratories 98

Research Laboratories Pharmaceutical Companies Pharmaceutical Companies Hospitals 98

European Pharmaceutical Review

JANUARY 24, 2023

At Parexel, Sandra held roles in Phase I project management and business development, before being promoted to a senior portfolio director in 2015. The company supports global drug development in primarily conducting Phase II and Phase III clinical trials.

Drug Development 98

Drug Development 98

pharmaphorum

AUGUST 17, 2022

Together, we aim at making the drug discovery process more efficient and effective in particular when very limited information is available to support drug design.”. A recent report from GlobalData predicted that pharma spending on AI drug discovery would hit $3 billion in 2025.

Compounding 97

Compounding Drug Development 97

pharmaphorum

JANUARY 9, 2023

is to acquire the 2015-established Amryt Pharma Plc. The development is for expansion of the company’s in-house drug development of biologicals and rare disease targeting and the site is due to become operational from 2024, with FDA, IFA, and EMA approvals due to be sought for 2025. in an all-cash transaction at $14.50

Drug Development 98

Drug Development 98

Safe Biologics

NOVEMBER 12, 2023

This is the first biosimilar approved to treat systemic juvenile idiopathic arthritis, and the 43rd biosimilar approved by the FDA since 2015. Pitts: The IRA makes the risks of developing new drugs too high On September 14th, an op-ed by former FDA Associate Commissioner Peter J. Read more about the approval here.

Biosimilars 130

Biosimilars Drug Pricing Packaging Labelling 130

pharmaphorum

SEPTEMBER 29, 2020

As of 2018, there were over 1,100 cancer therapies in development, and as of 2020, 362 of them were cell and gene therapies. As a result, there is a need for continued innovation and increased efficiency in terms of drug development to manage cost, complexity and speed to provide potentially transformative therapies for cancer patients.

Drug Development 132

Drug Development Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 132

Pharma Marketing Network

MARCH 25, 2022

The FDA has studied the importance of caregivers to drug development and regulatory decision-making. 2015-2017 Behavioral Risk Factor Surveillance System (BRFSS) Data from adults in 44 States, Puerto Rico, and the District of Columbia. Additional concerns for the caregiver include a strain on physical and mental health.

Labelling 98

Labelling Drug Development 98

pharmaphorum

JUNE 10, 2025

Skip to main content Tuesday 10 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 95

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 95

Pharmaceutical Technology

NOVEMBER 2, 2022

In 2015, China reformed its regulatory system, which introduced review designations, including fast-track programmes to increase drug development for unmet medical needs such as rare diseases and serious conditions.

Drug Development 59

Drug Development 59

European Pharmaceutical Review

SEPTEMBER 20, 2023

Although this evolution has led to life-changing medications, it also calls on drug development and manufacturing experts to identify new, more efficient ways to deliver high‑quality products. Pharmaceutical development is driven by quality by design (QbD) – an approach recommended by regulatory agencies. 2015; 7(5): 881-90.

Drug Development 98

Drug Development 98

pharmaphorum

OCTOBER 29, 2020

Since 2009 the agency has added further charged-for services; in 2015 NICE added the Office for Market Access (OMA). Note the light service has been incorporated into the standard service. Light was previously aimed at small and medium sized enterprises. Great job!”.

Documentation 101

Documentation Drug Development 101

pharmaphorum

APRIL 11, 2022

Dudley Tabakin, CEO of VivoSense, describes how this financing is set to accelerate the development of novel digital biomarkers and improve digital clinical outcome assessments. VivoSense software is developed specifically for analysis of data from wearable sensors”, explains Tabakin. “The

Pharmaceutical Companies 111

Pharmaceutical Companies Pharmaceutical Companies Drug Development Packaging 111

pharmaphorum

JUNE 8, 2021

All these factors will support the growth of in-house R&D-driven pharmaceutical companies and bring more innovative drugs to Asian markets.”. New cancer cases in China increased from 4 million in 2015 to 4.4 million in 2019, and are estimated to increase to 5.7 million in 2030. of the global oncology market in the same year.

Chemotherapy 105

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Immunization 105

Pharmaceutical Technology

MAY 3, 2023

Since 2015, the US Food and Drug Administration (FDA) has approved more than 450 “first generics” or the first generic equivalent for a branded drug. First generics are the first opportunity manufacturers have to market new generic drug products in the US.

Generic Medicine 98

Generic Medicine Drug Development Communication Diabetes 98

Express Pharma

SEPTEMBER 6, 2023

In a bid to resolve both physical and financial restrictions inhibiting equitable access to quality medicines, the Jan Aushadhi scheme was launched in 2008 and envisaged the setting up of dedicated Janaushadhi Kendras to provide quality generic medicines at capped prices for the general public.

Insurance Coverage and Processing 59

Insurance Coverage and Processing Biosimilars Generic Medicine Drug Pricing 59

European Pharmaceutical Review

DECEMBER 21, 2022

He is currently group leader of the Technology Development and Discovery Group at the Bioprocess Laboratory of the ETH. His research activities led to the foundation of five startup companies active in disciplines ranging from drug development to industrial biotech within the past 15 years. Green Chem 2015, 17, 123‒145.

Compounding 97

Compounding Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 97

pharmaphorum

FEBRUARY 3, 2021

billion, with London’s AIM seeing the highest levels of investment (£515 million) since 2015. The third was diagnostics company Verici Dx’s listing on the AIM which raised £14.5 million to support its next-generation sequencing platform to guide kidney transplants.

Drug Development 111

Drug Development Vaccines 111

European Pharmaceutical Review

MARCH 11, 2024

In fact, a study published in 2023 in The Lancet HIV revealed that women and men with HIV at age 40 had an average of 39 and 37 years of life left, respectively – only a few years less than that of the general population – if they started antiretroviral therapy (ART) after 2015. World Health Organization. The Global Health Observatory.

Immunization 98

Immunization Immunity Clinical Pharmacology Drug Development 98

PharmaTech

JUNE 23, 2025

FDA, Guidance for Industry, Naming of Drug Products Containing Salt Drug Substances (CDER, June 2015). USP, USP General Chapter , “Nomenclature,” USP35–NF30 (Rockville, MD, 2011). FDA, USP Salt Policy (December 2014). YouTube.com , Dec. 1, 2014 (accessed April 29, 2025).

Compounding 52

Compounding Dosage Labelling Drug Development 52

pharmaphorum

JUNE 14, 2022

A representation of the country’s rapidly developing capability can be seen in the example of WuXi Biologics, which is a contract development and manufacturing organisation, that was created in 2015 and is now in the top five companies in terms of manufacturing capacity for biologics.

Drug Development 98

Drug Development Vaccines 98

European Pharmaceutical Review

JULY 5, 2022

The availability of oral chemotherapy treatments would provide stomach cancer patients with the option of more efficacious drugs with improved tolerability in a more convenient dosage format” The poor clinical outcomes of stomach cancer make it a key target for drug development. 2015; 35(3):1437-45. Anticancer Res.

Chemotherapy 104

Chemotherapy Dosage Labelling Compounding 104

European Pharmaceutical Review

OCTOBER 19, 2022

FDA highlighted that over three quarters of new patents in the Orange Book between 2005 and 2015 were assigned to existing drugs. Biopharmaceutical Research & Development: The Process Behind New Medicines. Why 90% of clinical drug development fails and how to improve it? link] [Cited 25 September 2022].

Biosimilars 96

Biosimilars Dosage Drug Pricing Pharmaceutical Companies 96

European Pharmaceutical Review

MAY 29, 2023

Despite this, only 13 nanomedicines had been approved by the US Food and Drug Administration (FDA) before 2015. Another 563 new nanomedicines were under clinical trial or in other stages of drug development. Yet in 2021, 100 nanomedicines had been marketed.

Process Improvement 95

Process Improvement Packaging Drug Development Vaccines 95

pharmaphorum

SEPTEMBER 16, 2022

Well, Kim believes that “by leveraging the power of genetics and functional genomics, coupled with a ‘human-first’ mindset, innovative analytics, and scalable compute power” there is “the ability to take a fundamentally different approach to drug development”. It also bodes well for improving clinical trial success rates.

Immunization 135

Immunization Immunity Drug Development 135

European Pharmaceutical Review

MAY 11, 2023

Sitra joined Avexis in 2019 as Head of Clinical Development for SMA. In 2015, she joined Astellas Pharma, Northbrook, IL, and served as Global Lead for Immunology, CNS and Neuromuscular Indications and eventually as Global Medical Lead for the Muscle TA.

Drug Development 95

Drug Development 95